DE   EN   ES   FR   IT   PT


medicalmeds.eu Medicines Regeneranta and reparant. Vitreous

Vitreous

Препарат Стекловидное тело. РУП "Белмедпрепараты" Республика Беларусь


Producer: RUP of Belmedpreparata Republic of Belarus

Code of automatic telephone exchange: D03A

Release form: Liquid dosage forms. Solution for injections.

Indications to use: Asthenic syndrome. Dystrophy. Neuritis. Polyneuritis. Radiculitis. Neuralgia. Stump neuralgia. Keloid cicatrixes. Contractures. Keratitis. Helcoma. Cornea burn. Fracture of bones.


General characteristics. Structure:

Drug from a vitreous of eyes of the cattle.




Pharmacological properties:

Pharmacodynamics. Drug exerts the stimulating impact on formation of a bone callosity, reduces pain at damages of peripheral nerves. Softens cicatricial fabric and promotes its rassasyvaniye.


Indications to use:

Apply at nervous and physical overfatigue, the general breakdown, astenisation, nutritional and postinfectious dystrophy, neuritis, polyneurites, radiculitises, neuralgia, a stump neuralgia, to prevention of excess growth of connecting fabric in the early postoperative period, to a softening and a rassasyvaniye of cicatricial fabric, to treatment burn, postoperative, keloid and other origin of extensive hems, contractures of joints, at a keratitis, ulcers and burns of a cornea, to acceleration of formation of a bone callosity at changes.


Route of administration and doses:

The drug is administered under skin on 2 ml daily.

Course of treatment at neuralgia — 8 — 10 days, at hems, contractures and changes — up to 25 days.

Repetition of a course of treatment is recommended in one month or later.


Features of use:

With care appoint drug to patients with burdened allergoanamnezy.


Side effects:

Are not revealed.


Interaction with other medicines:

The negative phenomena at use of drug along with other medicines are noted.


Contraindications:

Infectious diseases, acute inflammatory processes, cachexia, nephrite, nephrosclerosis, cirrhosis, congestive heart failure with hypostases, malignant tumors.


Overdose:

So far the overdose phenomena at use of the drug "Vitreous" are not described.



Issue conditions:

According to the recipe


Packaging:

Solution for injections in ampoules of 2 ml in packaging No. 10.



  • Сайт детского здоровья